This content is machine translated Respiratory syncytial virus in the elderly A danger that is still underestimated Although respiratory syncytial virus (RSV) is one of the most common childhood infections and has a high morbidity and mortality rate in newborns and infants, the disease can occur in…
View Post 6 min This content is machine translated RSV in immunosuppression and transplantation Risk for HSCT and SOT recipients Although respiratory syncytial virus (RSV) is primarily known for its high burden of disease in infants and young children, it is increasingly recognized as an important cause of severe respiratory…
View Post 5 min This content is machine translated Respiratory syncytial virus (RSV) Diabetes as a highly significant risk factor for severity RSV is a common pathogen not only in older seniors over 65 years of age, but also in middle-aged patients between 50 and 64 years of age. In older adults…
View Post 5 min This content is machine translated Respiratory syncytial virus Unholy alliance of asthma and RSV In asthma patients, respiratory syncytial virus (RSV) infections can lead to an exacerbation of the disease by infecting the epithelial layer of the airways and triggering a subsequent immune response.…
View Post 5 min This content is machine translated Respiratory syncytial virus A question of seasonality Epidemiologic evidence suggests that respiratory syncytial virus (RSV) may have similar effects to non-pandemic influenza in older adults. Dutch researchers have investigated the extent to which RSV seasonality and latitude/region…
View Post 3 min This content is machine translated Respiratory syncytial virus (RSV) New vaccine candidate receives CHMP recommendation The positive opinion of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) is based on Phase III study data showing statistically significant and clinically meaningful…
